Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.84 USD | -3.01% | -11.68% | -14.34% |
May. 09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
May. 08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.34% | 333M | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+38.59% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- CCCC Stock
- News C4 Therapeutics, Inc.
- C4 Therapeutics Says US FDA Clears Investigational New Drug Application for CFT8919; Shares Rise Pre-Bell